300314.SHE Ningbo David Medical Device Co Ltd
- Market cap
- CNY 3.87B
- P/E
- 42.0x
- P/B
- 3.01x
- ROE
- 8.1%
- Dividend yield
- 0.65%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300314.SHE undervalued?
Graham number300314.SHE trades 137.0% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ningbo David Medical Device Co Ltd fundamental analysis
No fundamental analysis for Ningbo David Medical Device Co Ltd yet.
Ningbo David Medical Device Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ningbo David Medical Device Co Ltd
Ningbo David Medical Device Co., Ltd. engages in the research and development, production, and sales of pediatric childcare equipment, surgical instruments and other products worldwide. The company provides infant incubators, transport incubators, infant radiant warmers, neonate bilirubin phototherapy equipment, infant resuscitators, etc. It offers infusion pumps, transcutaneous jaundice detectors, infant t-piece resuscitators, air/oxygen blenders, low pressure aspirators, a…
Full company profileNingbo David Medical Device Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Ningbo David Medical Device Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 265M | 304M | 300M | 356M | 460M | 474M | 506M | 618M | 527M | 584M | 562M |
| Gross Profit | 141M | 155M | 151M | 190M | 270M | 289M | 296M | 355M | 294M | 313M | 284M |
| Operating Income | 70.2M | 60.5M | 42.4M | 72.0M | 148M | 87.2M | 112M | 171M | 68.8M | 81.5M | 83.7M |
| EBITDA | 87.4M | 76.3M | 61.1M | 91.2M | 168M | 112M | 136M | 194M | 87.0M | 124M | 116M |
| Net Income | 62.2M | 47.0M | 28.8M | 62.1M | 136M | 80.2M | 97.4M | 148M | 57.3M | 87.1M | 104M |
| EPS | 0.22 | 0.16 | 0.10 | 0.22 | 0.47 | 0.28 | 0.34 | 0.51 | 0.20 | 0.30 | 0.36 |
| Balance Sheet | |||||||||||
| Total Assets | 839M | 867M | 886M | 965M | 1.12B | 1.16B | 1.25B | 1.37B | 1.41B | 1.49B | 1.52B |
| Total Liabilities | 90.5M | 89.0M | 93.1M | 136M | 169M | 165M | 193M | 211M | 242M | 259M | 232M |
| Shareholders' Equity | 749M | 778M | 793M | 829M | 954M | 991M | 1.06B | 1.16B | 1.17B | 1.23B | 1.29B |
| Cash & Short-term Investments | 183M | 174M | 147M | 564M | 674M | 687M | 742M | 792M | 676M | 484M | 551M |
| Total Debt | - | - | - | - | 469K | 590K | 14.5M | 13.7M | 8.82M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 77.0M | 54.7M | 70.0M | 88.6M | 138M | 51.5M | 112M | 135M | 93.9M | 89.2M | - |
| Capital Expenditure | 59.5M | 35.5M | 15.2M | 9.08M | 24.2M | 6.53M | 49.8M | 40.4M | 140M | 55.0M | 36.6M |
| Free Cash Flow | 17.4M | 19.2M | 54.7M | 79.5M | 114M | 44.9M | 61.8M | 94.8M | -45.8M | 34.2M | -20.2M |
| Ratios | |||||||||||
| ROE | 8.3% | 6.0% | 3.6% | 7.5% | 14.3% | 8.1% | 9.2% | 12.7% | 4.9% | 7.1% | 8.1% |
| ROA | 7.4% | 5.4% | 3.3% | 6.4% | 12.1% | 6.9% | 7.8% | 10.7% | 4.1% | 5.8% | 6.8% |
| Net Profit Margin | 23.5% | 15.5% | 9.6% | 17.4% | 29.6% | 16.9% | 19.2% | 23.9% | 10.9% | 14.9% | 18.4% |
| Debt to Equity | - | - | - | - | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Ningbo David Medical Device Co Ltd dividends
- Dividend yield
- 0.65%
- Forward dividend
- 0.08 CNY
- Payout ratio
- 28.8%
- Ex-dividend date
- May 12, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 25.1M | 0.09 | 28.8% |
| 2024 | CNY 51.8M | 0.18 | 90.5% |
| 2023 | CNY 43.2M | 0.15 | 29.3% |
| 2022 | CNY 28.8M | 0.10 | 29.6% |
| 2021 | CNY 43.2M | 0.15 | 53.9% |
| 2020 | CNY 11.5M | 0.04 | 8.5% |
| 2019 | CNY 25.9M | 0.09 | 41.8% |
| 2018 | CNY 14.4M | 0.05 | 50.0% |
| 2017 | CNY 17.3M | 0.06 | 36.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 18:10 on May 20, 2015.
Who owns Ningbo David Medical Device Co Ltd
- Insiders 68.31%
- Institutions 1.19%
- Public & others 30.51%
- Shares outstanding 288M
- Free float 95.7M
Ningbo David Medical Device Co Ltd company profile
- Company name
- Ningbo David Medical Device Co Ltd
- Ticker
- 300314.SHE
- ISIN
- CNE100001DD1
- Exchange
- Shenzhen Stock Exchange
- Listed since
- May 8, 2012
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 920
- Fiscal year end
- December
- Address
- No. 2, Keyuan Road, Ningbo, China, 315731
- Phone
- 86 40 0853 3221
- Website
- nbdavid.com
About Ningbo David Medical Device Co Ltd
Ningbo David Medical Device Co., Ltd. engages in the research and development, production, and sales of pediatric childcare equipment, surgical instruments and other products worldwide. The company provides infant incubators, transport incubators, infant radiant warmers, neonate bilirubin phototherapy equipment, infant resuscitators, etc. It offers infusion pumps, transcutaneous jaundice detectors, infant t-piece resuscitators, air/oxygen blenders, low pressure aspirators, and infant oxygen hoods. The company offers its products under David brand name. The company founded in 1992 and is headquartered in Ningbo, China.
Ningbo David Medical Device Co Ltd management
7- Mr. Zaihong ChenGM & Chairman · born 1969
- Mr. Zedong LiCFO & Director · born 1973
- Mr. Yongwei YuDeputy GM & Non-Independent Director · born 1976
- Mr. Zhi'ang ChenSecretary & Non-Independent Director · born 1984
- Mr. Ding Yu LinDeputy General Manager · born 1973
- Mr. Wenqian ZhouDeputy General Manager · born 1976
- Yanjun LiuAccounting Supervisor